Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2007-10-09
2007-10-09
Saeed, Kamal A. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C544S330000, C544S331000, C544S122000
Reexamination Certificate
active
10746607
ABSTRACT:
Novel compounds and methods of using those compounds for the treatment of oncological conditions are provided. In a preferred embodiment, modulation of the activation states of abl or bcr-abl α-kinase proteins comprises the step of contacting the kinase proteins with the novel compounds.
REFERENCES:
patent: 4296237 (1981-10-01), Cragoe, Jr.
patent: 4366189 (1982-12-01), Burdeska et al.
patent: 4432992 (1984-02-01), Cragoe, Jr. et al.
patent: 5103014 (1992-04-01), Musser et al.
patent: 5494925 (1996-02-01), Court et al.
patent: 6020357 (2000-02-01), Pinto et al.
patent: 6166219 (2000-12-01), Yamasaki et al.
patent: 6235786 (2001-05-01), Dai et al.
patent: 6294573 (2001-09-01), Curtin et al.
patent: 6319921 (2001-11-01), Cirillo et al.
patent: 6352985 (2002-03-01), Yamasaki et al.
patent: 2001/0008898 (2001-07-01), Tomiyama et al.
patent: 2003/0181411 (2003-09-01), Bosch et al.
patent: 2003/0186221 (2003-10-01), Lockhart et al.
patent: 2005/0288286 (2005-12-01), Flynn et al.
patent: 2134915 (1993-11-01), None
patent: 2 156 343 (1972-05-01), None
patent: 2 341 064 (1974-03-01), None
patent: 4302702 (1994-08-01), None
patent: 4337847 (1995-05-01), None
patent: 4343831 (1995-06-01), None
patent: 44 14 840 (1995-11-01), None
patent: 4414840 (1995-11-01), None
patent: 0021228 (1981-01-01), None
patent: 0025232 (1981-03-01), None
patent: 0739884 (1996-10-01), None
patent: 0867435 (1998-09-01), None
patent: 0927555 (1999-07-01), None
patent: 0956855 (1999-11-01), None
patent: 1281399 (2003-02-01), None
patent: 2 337 554 (1977-08-01), None
patent: 2 396 549 (1979-02-01), None
patent: 971307 (1964-09-01), None
patent: 1127875 (1967-03-01), None
patent: 2276161 (1984-09-01), None
patent: 2220206 (1990-01-01), None
patent: 59-15247 (1984-01-01), None
patent: 59-177557 (1984-10-01), None
patent: 9-221476 (1997-08-01), None
patent: 10-7804 (1998-01-01), None
patent: 11-209350 (1999-08-01), None
patent: 2000-275886 (2000-10-01), None
patent: 2001-2687 (2001-01-01), None
patent: WO9119708 (1991-12-01), None
patent: WO9208693 (1992-05-01), None
patent: WO9424095 (1994-10-01), None
patent: WO9515954 (1995-06-01), None
patent: WO9534540 (1995-12-01), None
patent: WO9616046 (1996-05-01), None
patent: WO9619477 (1996-06-01), None
patent: WO9734900 (1997-09-01), None
patent: WO9822103 (1998-05-01), None
patent: WO9915164 (1999-04-01), None
patent: WO9923093 (1999-05-01), None
patent: WO9959959 (1999-11-01), None
patent: WO0002851 (2000-01-01), None
patent: WO0007980 (2000-02-01), None
patent: WO0018738 (2000-04-01), None
patent: WO0021927 (2000-04-01), None
patent: WO0041698 (2000-07-01), None
patent: WO0043384 (2000-07-01), None
patent: WO0059506 (2000-10-01), None
patent: WO0112621 (2001-02-01), None
patent: WO0114372 (2001-03-01), None
patent: WO0174771 (2001-10-01), None
patent: WO0196298 (2001-12-01), None
patent: WO0214291 (2002-02-01), None
patent: WO0228835 (2002-04-01), None
patent: WO0234727 (2002-05-01), None
patent: WO0240458 (2002-05-01), None
patent: WO02060869 (2002-08-01), None
patent: WO02060876 (2002-08-01), None
patent: WO03000189 (2003-01-01), None
patent: WO03053368 (2003-07-01), None
patent: WO03059373 (2003-07-01), None
patent: WO03072577 (2003-09-01), None
O'Dell, J., et al. “Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications,” New. Eng. J. Med., vol. 334(20), pp. 1287-1291 (May 1996), at p. 1287, col. 1, lines 6-9.
Dumas, “Protein Kinase Inhibitors: Emerging From a Pharmacophores 1997-2000”, Expert Opinion on Therepeudic Patents, (2001), vol. 11, pp. 405-429.
Schindler et al., “Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase”, Science, (Sep. 15, 2000), vol. 289, pp. 1938-1942.
Pargellis et al., “Inhibition of P38 MAp Kinase by Utilizing a Novel Allosteric Binding Site”, Nature Structural Biology, (Apr. 2002), vol. 9, pp. 268-272.
Nofal et al., “Synthesis of Novel Uracil-5-Sulphonamide Derivatives of Possible Biological Activity”, Egypt Journal of Chemistry, (1990), vol. 33, pp. 375-380.
Johnson et al., “The Stereochemistry Oxidation at Sulfur”, Tetrahedron, (1969), vol. 25, pp. 5649-5653.
Griffith et al., “TPAP: Tetra-In-Propylammonium Perruthenate, a Mild and Convenient Oxidant for Alcohols”, Aldrichimica Acta, (1990), vol. 23, pp. 13-19.
Zvilichovsky et al., “Aminolysis and Polymerization 3-(p-toluenesulfonoxy) Hydantoin”, Israel Journal of Chemistry, (1969), vol. 7, pp. 547-554.
Yang et al., “Palladimum-Catalyzed Amination of Aryl Halides and Sulfonates”, Journal of Organlmetallic Chemistry, (1999), vol. 576, pp. 125-146.
Kwong et al., “A General, Efficient, an Inexpensive Catalyst System for the Coupling of Aryl Iodies and Thiols”, Organic Letters, (2002), vol. 4, pp. 3517-3520.
Leca et al., “A New Practical 1-Pot Access to Sulfonimidates”, Organic Letters, (2002), vol. 4, pp. 4093-4095.
Cheng et al., “Novel Solution Phase Strategy for the Synthesis of Chemical Libraries Containing Small Organic Molecules”, Journal American Chemical Society, (1996), vol. 118, pp. 2567-2573.
Dess et al., “A Useful 12-I-5 Triacetoxyperiodinane (the Dess-Martin Periodinane) for the Selective Oxidation of Primary or Secondary Alcohols in a Variety of Related 12-I-5 Species”, Journal American Chemical Society , (1991), vol. 113, pp. 7277-7287.
Bausch et al., “Proton-transfer Chemistry of Urazoles and Related Imides, Amides and Diacyl Hydrazides”, Journal Organic Chemistry, (1991), vol. 56, pp. 5643-5651.
Muller et al., “A General Synthesis of 4-substituted 1, 1-Dioxo-1, 2, 5-thiadiazolidin-3-ones Derived From a-Amino Acids”, The Journal of Organic Chemistry, (1989), vol. 54, pp. 4471-4473.
Klyman et al., “The Reaction of S-Methiodide Derivatives of Activated Thioureas with Hydroxylic Compounds. A Novel Synthesis of Mercaptans”, Journal of Organic Chemistry, (1972), vol. 37, pp. 1532-1537S.
Tremblay et al., “Efficient Solid-Phase Synthesis of Sulfahydantoins”, Journal of Combinatorial Chemistry, (2002), vol. 4, pp. 429-435.
Peng et al., “Identification of Novel Inhibitors of BCR-ABL Tyrosine Kinase via Virtual Screening”, Journal of Bioorganic and Medicinal Chemistry Letters, (2003), vol. 13, pp. 3693-3699.
Huse et al., “Conformational Plasticity of Protein Kinases”, Cell, (2002), vol. 109, pp. 275-282.
Teague, “Implications of Protein Flexibility for Drug Discovery”, Nature Reviews, (Jul. 2003), vol. 2, pp. 527-541.
Wu et al., “Discovery of a Novel Family of CDK Inhibitors with the Program LIDAEUS: Structural Basis for Ligand-Induced Disordering of the Activation Loop”, Structure, (2003), vol. 11, pp. 399-410.
Askew et al., “Molecular Recognition with Convergent Functions Groups. Synthetic Instructural Studies with a Model Receptor for Nucleic Acid Components”, Journal of American Chemical Society, (1989), vol. 111, pp. 1082-1090.
Regan et al., “Pyrazole Urea-Based Inhibitors of p38MAP Kinase: From Lead Compound to Clinical Candidate”, Journal of Medicinal Chemistry, (2002), vol. 45, pp. 2994-3008.
Venter, et al., “The Sequence of the Human Genome”, Science, (2001), vol. 291, pp. 1304-1351.
“Initial Sequencing and Analysis of the Human Genome”, Nature, (2001), vol. 409, pp. 860-921.
Wollter et al., “Copper-Catalyzed Coupling of Aryl Iodides with Aliphatic Alcohols”, Organic Letters, (2002), vol. 4, pp. 973-976.
Martinez et al., “First Non-ATP Competitive Glycogen Synthase Kinase 3β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease”, Journal of Medicinal Chemistry , (2002), vol. 45, pp. 1292-1299.
Almerico et al., “On the Preparation of 1-Aryl-2-Heteroaryl- and 2-Aryl-1-Heteroaryl-Pyrroles as Useful Building Blocks for Biologically
Flynn Daniel L.
Petillo Peter A.
Deciphera Pharmaceuticals LLC
Hovey & Williams, LLP
Saeed Kamal A.
Shiao Rei-tsang
LandOfFree
Anti-cancer medicaments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-cancer medicaments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-cancer medicaments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3823425